The Effect of the HEP Approach in Infants With Down Syndrome
Recruiting
N/A
Interventional Study
Down Syndrome (DS)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 4 Months – 12 Months
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 26 (estimated)
- Sponsor
- Izgi Miray Demirbag · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates the effect of the HEP (Homeostasis-Enrichment-Plasticity) approach on motor and sensory development in infants with Down syndrome. Thirty-two infants will receive either HEP or traditional therapy over 12 sessions, and outcomes will be measured using standardized developmental tests.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Must be between 4 and 12 months old
* Must have been diagnosed with Down Syndrome
* Must not be at any neurological risk
* Parent must agree to participate regularly in the study process
Exclusion Criteria:
* History of intraventricular hemorrhage (Grade III or IV)
* Major v…
Contacts